BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with $599 Million in Revenue Over Past Four Quarters Provides Opportunity to Expand Access to Galafold and Pombiliti + Opfolda to Patients in New Markets Across BioMarin's Global Footprint; Pending U.S. Galafold […]

Achieve, Jefferies close $271 million HELOC securitization

Eighth securitization of Achieve HELOCs is first to be rated by S&P Global Achieve, the leader in digital personal finance, announces the Dec. 16 close of a $271.2 million, AAA-rated securitization backed by newly originated home equity lines of credit (HELOCs). https://mma.prnewswire.com/media/1905050/Achieve_Logo.jpg The securitization, ACHM Trust 2025-HE3, includes six classes of rated, mortgage-backed notes and

Curaleaf Announces Termination of Equity Purchase Agreement with The Cannabist Company

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, announced the termination of its binding commitment to acquire The Cannabist Company's Virginia assets (the “Virginia Assets”). A competing bid valued the Virginia Assets at $130 million plus the assumption of a $30 million lease liability.

Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030

Issued on behalf of GT Biopharma, Inc. USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for second-line blood cancer treatment marks the departure from traditional chemotherapy that oncologists have been anticipating for decades[1]. Engineered cell therapies and bispecific antibodies are now achieving response rates exceeding

Chonnam National University Scientists Discover a Molecular Switch That Protects Crops from Freezing Cold

New findings uncover a rapid molecular switch that rewires plant growth under cold stress, opening pathways to climate-resilient crops A research team from Korea have uncovered how plants rapidly activate a hidden genetic “switch” helping them survive in cold environments. They demonstrate that low temperatures induce a rewiring of a hormone signaling pathway, triggering the

TNL Mediagene Issues Shareholder Letter Providing H2 and 2025 Corporate Update

TNLMediagene (Nasdaq: TNMG) (the “Company”), a Tokyo-based next-generation digital media and data group in Asia, today issued a letter to shareholdersfrom Joey Chung, Co-Founder and CEO, and Motoko Imada, Co-Founder and President of TNL Mediagene, discussing key recent positive and notable developments, milestones and achievements of the Company year-to-date in 2025 and plans for the

CONAGRA BRANDS REPORTS SECOND QUARTER RESULTS

Today Conagra Brands, Inc. (NYSE: CAG) reported results for the second quarter of fiscal year 2026, which ended on November 23, 2025. All comparisons are against the prior year fiscal period, unless otherwise noted. https://mma.prnewswire.com/media/479094/CB_CMYK_Texture_Logo.jpg Highlights — Reported net sales decreased 6.8%; organic net sales decreased 3.0%. — Reported operating margin was (20.1)%; adjusted operating

Manulife Investments Announces Estimated Reinvested Capital Gains Distributions for Manulife Exchange Traded Funds

C$ unless otherwise stated Manulife Investments today announced the 2025 annual reinvested distribution estimates for Manulife Exchange Traded Funds (ETFs). These annual reinvested distributions generally represent realized capital gains within the ETFs. Please note that these are estimated capital gains amounts only as of December 15, 2025, and reflect forward-looking information which may cause these

Manulife Investments Announces Estimated Cash Distributions for Manulife Exchange Traded Funds

C$ unless otherwise stated Manulife Investments today announced the December 2025 cash distribution estimates for Manulife Exchange Traded Funds (ETFs). Please note that these are estimated amounts only as of December 15, 2025, and reflect forward-looking information which may cause these estimates to change. Unitholders of record at the close of business on December 30,

The Return of KUKAN: An Oscar-Winning Documentary Legend Released Worldwide

A news report fromiChongqing-“Return of KUKAN”, a documentary produced by the Western China International Communication Organization, meticulously produced over one year, finally makes its debut-paying tribute to those who fought with tenacity against fascism. The launch follows Chongqing International Culture Association's donation of the restored documentary “KUKAN: The Secret of Unconquerable China” to the Academy

Scroll to Top